Incidence of endometrial cancer in BRCA mutation carriers.

Autor: Kotsopoulos J; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Lubinski J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Huzarski T; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Bychkovsky BL; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Moller P; Department of Tumour Biology, Institute of Cancer Research, The Norwegian Radium Hospital, 0379 Oslo, Norway., Kim RH; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Sinai Health System, Hospital for Sick Children, Ontario Institute for Cancer Research, Department of Medicine, University of Toronto, Canada., Tung N; Beth Israel Deaconess Medical Center, Boston, MA, USA., Eisen A; Toronto-Sunnybrook Regional Cancer Center, Toronto, ON, Canada., Foulkes W; McGill Program in Cancer Genetics, Department of Oncology, McGill University, Montreal, QC, Canada., Singer CF; Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Aeilts A; Division of Human Genetics, the Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, OH, USA., Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA., Bordeleau L; Department of Oncology, McMaster University, Hamilton, ON, Canada., Karlan B; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, CA, USA., Fruscio R; Clinic of Obstetrics and Gynecology, IRCCS Fondazione San Gerardo dei Tintori, Monza, Italy., Eng C; Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA., Olopade O; Department of Medicine and Human Genetics, University of Chicago, Chicago, IL, USA., Zakalik D; Cancer Genetics Program, Beaumont Hospital, Royal Oak, MI, USA., Couch F; Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Y Cajal TR; Familial Cancer Clinic, Medical Oncology, Hospital Santa Creu i Sant Pau, Barcelona, Spain., Sun P; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada., Gronwald J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Narod SA; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. Electronic address: steven.narod@wchospital.ca.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2024 Oct; Vol. 189, pp. 148-155. Date of Electronic Publication: 2024 Aug 21.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Breast Cancer High-Penetrance Genes BRCA1 and BRCA2 Mutations Using Next-Generation Sequencing Among Iraqi Kurdish Women.

Autor: Hassan AN; Department of Medical Laboratory Technology, Erbil Technical Health and Medical College, Erbil Polytechnic University, Erbil, IRQ., Mustafa MS; Department of Biology, College of Science, Salahaddin University-Erbil, Erbil, IRQ.

Publikováno v: Cureus [Cureus] 2024 Jun 11; Vol. 16 (6), pp. e62160. Date of Electronic Publication: 2024 Jun 11 (Print Publication: 2024).

Breast Cancer and Pregnancy in Young BRCA Carriers-Reply.

Autor: Blondeaux E; U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lambertini M; Department of Internal Medicine and Medical Specialties (DIMI), University of Genova, Genova, Italy.

Publikováno v: JAMA [JAMA] 2024 Apr 09; Vol. 331 (14), pp. 1234.

Determinação de mutações e polimorfismo nos genes BRCA1 e BRCA2 em pacientes com câncer de mama com indicação para teste genético

Autor: Escobar, Karina Augusto

Introdução: Mutações nos genes BRCA1 e BRCA2 são responsáveis por cerca de 50% dos casos de câncer de mama e/ou ovário hereditários. Atualmente não conhecemos o perfil de mutações destes genes na população brasileira, com exceção de m

Externí odkaz: http://www.teses.usp.br/teses/disponiveis/5/5155/tde-05092011-152557/